首页> 外国专利> Composition comprising a process of forming dried core particle topiramate coated with a taste masking substance followed by a binder further coated with a further taste masking substance and method for treating epilepsy and convulsions

Composition comprising a process of forming dried core particle topiramate coated with a taste masking substance followed by a binder further coated with a further taste masking substance and method for treating epilepsy and convulsions

机译:组合物,其包括形成涂覆有掩味物质的干燥的核心颗粒托吡酯,然后进一步涂覆有另一种掩味物质的粘合剂的方法以及治疗癫痫和惊厥的方法

摘要

A pharmaceutical composition can be formed by preparing core particles comprising the active agent topiramate, drying the particles to form dried core particles and then coating the dried particles with a taste masking mixture to form coated particles. The coated particles are then dried to form the composition. The amount of the taste masking agent ranges from about 7% to about 15% by weight of the pharmaceutical composition. Also described is a pharmaceutical composition comprising core particles having an initial particle size of between 0.1 mm and 2.5 mm and a taste masking coating that comprises about 7% to about 15% by weight of the composition. The composition can comprise 85 to 93% by weight core beads and 7 to 15% by weight of coating. The core beads comprise 18 to 21% by weight of topiramate and 8-11% by weight of povidone and 58 to 61% by weight of sugar. The coating comprises 6-9% by weight of cellulose acetate and 2 to 5% by weight of povidone. The compositions can be used for treating convulsion or epilepsy.
机译:可以通过制备包含活性剂托吡酯的核心颗粒,干燥颗粒以形成干燥的核心颗粒,然后用掩味混合物涂覆干燥的颗粒以形成涂覆的颗粒来形成药物组合物。然后将涂覆的颗粒干燥以形成组合物。掩味剂的量占药物组合物重量的约7%至约15%。还描述了药物组合物,其包含具有0.1mm至2.5mm的初始粒度的核心颗粒和占组合物重量的约7%至约15%的掩味涂层。该组合物可包含85至93重量%的芯珠和7至15重量%的包衣。核心珠包含18至21重量%的托吡酯和8至11重量%的聚维酮和58至61重量%的糖。该涂层包含6-9重量%的乙酸纤维素和2-5重量%的聚维酮。该组合物可用于治疗惊厥或癫痫。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号